Clevidipine Butyrate
Category: Blood PressureClevidipine Butyrate Overview
Clevidipine (INN,[1] trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008. Contents 1 Basic chemical and pharmacological properties 1.1 Stereochemistry 2 Dosage and administration 3 Safety information 4 Drug interactions 5 Storage 6 Phase III clinical trial results 7 References ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clevidipine
Recent Clevidipine Butyrate Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Clevidipine Butyrate
- Emulsion: 0.5mg/ml, 125mg/250ml (0.5mg/ml), 25mg/50ml (0.5mg/ml), 25mg/50ml(0.5mg/ml), 50mg/100ml (0.5mg/ml), 50mg/100ml(0.5mg/ml)
Other drugs which contain Clevidipine Butyrate or a similar ingredient: (1 result)
- CLEVIPREX Clevidipine Butyrate
Related Clevidipine Butyrate Topics:
Clevidipine Butyrate
unfortuneately, i have no idea what this pill looks like. my son was an addict yrs ago, but has recently aquired this dr...
unfortuneately, i have no idea what this pill looks like. my son was an addict yrs ago, but has recently aquired this dr...